방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 신장 질환 삶의 질 척도× | EORTC QLQ-C30× | |
|---|---|---|
| 분야 | 건강 결과 | 건강 결과 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1994 | 1993 |
| 창시자≠ | Ron D. Hays et al. | Nico Aaronson et al. |
| 유형 | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| 원전≠ | Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., & Carter, W. B. (1994). Development of the Kidney Disease Quality of Life (KDQOL) instrument. Quality of Life Research, 3(5), 329-338. DOI ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| 별칭 | KDQOL, Kidney Disease QoL, KDQOL-SF | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| 관련≠ | 4 | 5 |
| 요약≠ | The KDQOL is the most widely used quality of life measure for chronic kidney disease (CKD) patients, particularly those on dialysis. Developed by Ron Hays and colleagues in 1994, this multidimensional questionnaire (full version 134 items; short-form KDQOL-SF 36 items) measures kidney disease-specific impacts on physical function, emotional well-being, social participation, and treatment burden. It is the standard outcome measure in renal research and clinical practice. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGate데이터셋 ↗ |
|
|